Incumbents Strike Back

Innovation will be driven through a focus on external factors according to this report from IBM. New research found that 68 per cent of c-suite executives expect organisations to emphasise customer experience over products.

Key points incude:

  • Reinvention never ends. As new opportunities – some of them disruptive – emerge, the organizations that remain open to change can orchestrate advantage.
  • To create a more open and collaborative culture, look for ways to challenge traditional norms.
  • Boldly evaluate, experiment and engage with new business models, industry-shaping platforms and ecosystem strategies.
  • Create opportunities for frequent and intense interactions with customers, partners and competitors.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
AI and Human Interaction: App...

Generative AI promises to be the next great leap forward in artificial intelligence. But to deliver on this promise, brands must adopt an approach that puts humans at the center. In this report, Criticaleye’s CEO ...

Click here to download this insight
Responsible AI at Eightfold

Artificial Intelligence, a force with the potential to revolutionise various aspects of people's lives and business operations, demands responsible and ethical decision-making. This is particularly crucial in HR. Cr...

Click here to download this insight
HR Director Research Results ...

This research, conducted at our HR Director Retreat, highlights the executive focus on business performance and ensuring the right leadership capabilities are in place to drive change and success. Key findings from C...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 1,488




Legal & General Investment Management Eton Bridge Partners NATS London Stock Exchange AlixPartners Mayborn Group Accenture Tullow Oil plc Royal London Group Google Workday Eightfold AI Salesforce Redwood Bank Amazon UK Drax Group plc Robert Walters Veolia Water Technologies GlaxoSmithKline plc Bunzl plc Lightsource bp Concentrix LDC E.ON UK